VKORC1L1 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with VKORC1L1 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with VKORC1L1 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with VKORC1L1 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with VKORC1L1 Up.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000161980 - RNA polymerase III subunit K

Gene

ENSG00000115685 - protein phosphatase 1 regulatory subunit 7

Gene

ENSG00000132463 - G-rich RNA sequence binding factor 1

Gene

ENSG00000125534 - pancreatic progenitor cell differentiation and proliferation factor

Gene

ENSG00000135930 - eukaryotic translation initiation factor 4E family member 2

Gene

ENSG00000175550 - DR1 associated protein 1

Gene

ENSG00000134072 - calcium/calmodulin dependent protein kinase I

  • Gene

    ENSG00000161980 - RNA polymerase III subunit K


  • Gene

    ENSG00000115685 - protein phosphatase 1 regulatory subunit 7


  • Gene

    ENSG00000132463 - G-rich RNA sequence binding factor 1


  • Gene

    ENSG00000125534 - pancreatic progenitor cell differentiation and proliferation factor


  • Gene

    ENSG00000135930 - eukaryotic translation initiation factor 4E family member 2


  • Gene

    ENSG00000175550 - DR1 associated protein 1


  • Gene

    ENSG00000134072 - calcium/calmodulin dependent protein kinase I

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.